Xue-Yan Cui, MD, PhD, Oslo University Hospital, Oslo, Norway, briefly explains how a better understanding of the bone marrow microenvironment in precursor stages of myeloma can improve treatment approaches and possibly prevent disease progression. This interview took place at the 30th Congress of the International Society on Thrombosis and Haemostasis (ISTH) 2022 held in London, UK.